Ming‐Jo Hsu - Concepedia

Author

Ming‐Jo Hsu

Merck & Co., Inc., Rahway, NJ, USA (United States)

Also Known As

Ming-Jo Hsu, Ming‐Jo Hsu

Publications

701

Citations

H-Index

Concepts

All Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)

About

Ming‐Jo Hsu is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, pharmacology, and antifungal agents.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	326
2	Biochemistry	3	3	102
3	Natural Sciences	2	2	73
4	Engineering	1	1	82
5	Cell Biology	1	1	20

Ming‐Jo Hsu

Publications

691

Citations

H-Index

Page 1

	Year	Citations
Elongation Factor 2 as a Novel Target for Selective Inhibition of Fungal Protein Synthesis Michael Justice, Ming‐Jo Hsu, Bruno Tse, Journal of Biological Chemistry	1998	190
Acquired Echinocandin Resistance in a <i>Candida krusei</i> Isolate Due to Modification of Glucan Synthase Jennifer Nielsen Kahn, Guillermo García‐Effrón, Ming‐Jo Hsu, Antimicrobial Agents and Chemotherapy	2007	118
PAP Inhibitor with In Vivo Efficacy Identified by Candida albicans Genetic Profiling of Natural Products Bo Jiang, Deming Xu, John Allocco, Chemistry & Biology Antifungal AgentEngineeringMedicineVivo Efficacy IdentifiedGenetic Engineering	2008	82
Caspofungin Susceptibility in <i>Aspergillus</i> and Non- <i>Aspergillus</i> Molds: Inhibition of Glucan Synthase and Reduction of β- <scp>d</scp> -1,3 Glucan Levels in Culture Jennifer Nielsen Kahn, Ming‐Jo Hsu, Fred Racine, Antimicrobial Agents and Chemotherapy MycologyGenera AlternariaAntifungal AgentAspergillus Spp.Antifungal Agents	2006	61
Mutations in Ribosomal Protein L10e Confer Resistance to the Fungal-specific Eukaryotic Elongation Factor 2 Inhibitor Sordarin Michael Justice, Theresa Ku, Ming‐Jo Hsu, Journal of Biological Chemistry	1999	57
Species-specific inhibition of fungal protein synthesis by sordarin: identification of a sordarin-specificity region in eukaryotic elongation factor 2 The GenBank accession numbers for the sequences reported in this manuscript are AF107286–AF107291, AF292693 and AF248644. M.C.R. Shastry, Jennifer Nielsen, Theresa Ku, Microbiology BiosynthesisSordarin ClassBiochemistryFungal Cell BiologyNatural Sciences	2001	53
Ibrexafungerp: An orally active β-1,3-glucan synthesis inhibitor James M. Apgar, Robert R. Wilkening, Dann L. Parker, Bioorganic & Medicinal Chemistry Letters MedicineImmunologyPharmacotherapyAnti-cancer AgentPharmacology	2020	48
Isolation and structure elucidation of parnafungins C and D, isoxazolidinone-containing antifungal natural products David P. Overy, Kathleen Calati, Jennifer Nielsen Kahn, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryAntifungal AgentParnafungins CBioassay-guided IsolationAntifungal Agents	2008	33
Alkyl side-chain derivatives of sordaricin as potent antifungal agents against yeast Bruno Tse, James M. Balkovec, Charles M. Blazey, Bioorganic & Medicinal Chemistry Letters Alkyl Side-chain DerivativesAntifungal AgentBiochemistryAntifungal AgentsMedicine	1998	29
Regulation of PGI2 activity by serum proteins: serum albumin but not high density lipoprotein is the PGI2 binding and stabilizing protein in human blood Ah‐Lim Tsai, Ming‐Jo Hsu, Wolfgang Patsch, Biochimica et Biophysica Acta (BBA) - General Subjects Protein FunctionSignal TransductionSerum AlbuminBiochemistryG Protein-coupled Receptor	1991	20

Page 1